Virbac has established a local manufacturing partnership in China to meet the growing demand for veterinary products, enhancing its competitive position in the rapidly expanding pet care market.

Information on the Target

Virbac, a global leader in animal health, specializes in the development of a wide range of veterinary products for both companion animals and farm animals. Their portfolio includes innovative solutions for nutrition, dermatology, vaccines, and other health-related products. With a focus on ensuring animal welfare and preserving the human-animal bond, Virbac is committed to enhancing the quality of life for pets and livestock alike.

Recently, Virbac has made significant strides in the Chinese market by establishing a local manufacturing partnership. This strategic initiative is designed to meet the growing demand for veterinary products stemming from China’s expanding pet ownership and rising middle class. By localizing production, Virbac aims to increase the availability of essential health solutions tailored specifically for Chinese consumers.

Industry Overview in China

The animal health industry in China is experiencing rapid growth, driven by a burgeoning middle class and an increasing number of pet ownership. The country's pet population is expanding at an unprecedented rate, leading to a correspondingly hig

View Source

Similar Deals

TRASIS Beijing PET Technology

2025

Joint Venture In-Vivo Diagnostic & Testing Substances China
STADA Bio-Thera Solutions

2025

Joint Venture Biopharmaceuticals China
VivaVision Jiangxi Shanliang Pharmaceutical Co., Ltd.

2024

Joint Venture Proprietary & Advanced Pharmaceuticals China
Aditum Bio Oblenio Bio

2023

Joint Venture Bio Therapeutic Drugs China
Wolters Kluwer Medicom

Joint Venture Hospitals, Clinics & Primary Care Services China
CPE Burger King

2026

Joint Venture Food Markets China

Virbac

invested in

local manufacturing partnership

in 2025

in a Joint Venture deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert